<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>3(4)</volume><submitter>Cruz PG</submitter><pubmed_abstract>Two new brominated bis(indole) alkaloids, dragmacidins I (1) and J (2), showing low micromolar cytostatic activity, along with three known congeners were isolated from the Tanzanian sponge &lt;i>Dragmacidon&lt;/i> sp. and their structures determined by the analysis of their NMR and MS data. From the study of their mechanism of action, it can be concluded that the mitotic arrest at metaphase in treated tumor cells, mediated by inhibition of PP1 and/or PP2A phosphatases is involved in the observed antiproliferative activity. Differences in their bioactivities were rationalized, and a plausible binding mode is proposed on the basis of computational simulations.</pubmed_abstract><journal>ACS omega</journal><pagination>3760-3767</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6045348</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>On the Mechanism of Action of Dragmacidins I and J, Two New Representatives of a New Class of Protein Phosphatase 1 and 2A Inhibitors.</pubmed_title><pmcid>PMC6045348</pmcid><pubmed_authors>Daranas AH</pubmed_authors><pubmed_authors>Cruz PG</pubmed_authors><pubmed_authors>Cuevas C</pubmed_authors><pubmed_authors>Martinez Leal JF</pubmed_authors><pubmed_authors>Perez M</pubmed_authors></additional><is_claimable>false</is_claimable><name>On the Mechanism of Action of Dragmacidins I and J, Two New Representatives of a New Class of Protein Phosphatase 1 and 2A Inhibitors.</name><description>Two new brominated bis(indole) alkaloids, dragmacidins I (1) and J (2), showing low micromolar cytostatic activity, along with three known congeners were isolated from the Tanzanian sponge &lt;i>Dragmacidon&lt;/i> sp. and their structures determined by the analysis of their NMR and MS data. From the study of their mechanism of action, it can be concluded that the mitotic arrest at metaphase in treated tumor cells, mediated by inhibition of PP1 and/or PP2A phosphatases is involved in the observed antiproliferative activity. Differences in their bioactivities were rationalized, and a plausible binding mode is proposed on the basis of computational simulations.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Apr</publication><modification>2024-10-15T22:00:36.086Z</modification><creation>2019-03-26T23:47:02Z</creation></dates><accession>S-EPMC6045348</accession><cross_references><pubmed>30023878</pubmed><doi>10.1021/acsomega.7b01786</doi></cross_references></HashMap>